Literature DB >> 13275148

Spiramycin; clinical and laboratory studies.

D G HUDSON, G M YOSHIHARA, W M KIRBY.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS/effects; DIPLOCOCCUS PNEUMONIAE/effect of drugs on; MICROCOCCUS PYOGENES/effect of drugs on; STREPTOCOCCUS/effect of drugs on

Mesh：

Substances：

Year:  1956        PMID： 13275148     DOI： 10.1001/archinte.1956.00250190073005

Source DB:  PubMed          Journal:  AMA Arch Intern Med        ISSN： 0888-2479


× No keyword cloud information.
  7 in total

1.  The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin, and spiramycin.

Authors:  E J LOWBURY; L HURST
Journal:  J Clin Pathol       Date:  1959-03       Impact factor: 3.411

2.  [Sensitivity of some nonsporous anaerobes to spiramycin in vitro].

Authors:  U BERGER
Journal:  Z Hyg Infektionskr       Date:  1958

3.  Treatment of gonorrhoea with spiramycin.

Authors:  R R WILLCOX
Journal:  Br J Vener Dis       Date:  1956-06

4.  Behaviour in vitro of some new antistaphylococcal antibiotics.

Authors:  L P GARROD; P M WATERWORTH
Journal:  Br Med J       Date:  1956-07-14

Review 5.  Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

6.  Spiramycin for Toxoplasmosis.

Authors:  J V Cassady; J W Bahler; M V Hinken
Journal:  Trans Am Ophthalmol Soc       Date:  1963

Review 7.  Current recommendations and future prospects in the treatment of toxoplasmosis.

Authors:  R E McCabe; S Oster
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.